GB202103578D0 - Prevention and treatment of infections including those caused by coronavirus - Google Patents
Prevention and treatment of infections including those caused by coronavirusInfo
- Publication number
- GB202103578D0 GB202103578D0 GBGB2103578.7A GB202103578A GB202103578D0 GB 202103578 D0 GB202103578 D0 GB 202103578D0 GB 202103578 A GB202103578 A GB 202103578A GB 202103578 D0 GB202103578 D0 GB 202103578D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- coronavirus
- prevention
- treatment
- including those
- those caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2103578.7A GB2607262A (en) | 2021-03-15 | 2021-03-15 | Prevention and treatment of infections including those caused by coronavirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2103578.7A GB2607262A (en) | 2021-03-15 | 2021-03-15 | Prevention and treatment of infections including those caused by coronavirus |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202103578D0 true GB202103578D0 (en) | 2021-04-28 |
GB2607262A GB2607262A (en) | 2022-12-07 |
Family
ID=75623171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2103578.7A Withdrawn GB2607262A (en) | 2021-03-15 | 2021-03-15 | Prevention and treatment of infections including those caused by coronavirus |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2607262A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202004007D0 (en) * | 2020-03-19 | 2020-05-06 | Immodulon Therapeutics Ltd | Coronavirus |
CN111265500B (en) * | 2020-03-02 | 2022-02-01 | 广西医科大学第一附属医院 | Pharmaceutical composition for preventing and treating COVID-19 and preparation method thereof |
-
2021
- 2021-03-15 GB GB2103578.7A patent/GB2607262A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2607262A (en) | 2022-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT4204421T (en) | Compounds and methods for treatment of viral infections | |
EP3980400A4 (en) | Peptidomimetics for the treatment of coronavirus and picornavirus infections | |
EP4117630A4 (en) | Treatment of coronavirus infection | |
GB202005097D0 (en) | Treatment and/or prevention of covid-19 infection | |
EP4106752A4 (en) | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors | |
ZA202208630B (en) | Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia | |
IL277315B (en) | Methods and composition for treating coronavirus infection | |
EP4058037A4 (en) | Fibroblast-based therapy for treatment and prevention of stroke | |
EP4157255A4 (en) | Treatment of coronavirus | |
GB202013874D0 (en) | Treatment and prevention of viral infections | |
SG11202008791UA (en) | Agent for prevention and/or treatment of pseudomonas aeruginosa infection | |
IL312583A (en) | Composition for treatment and prevention of covid-19 | |
ZA202210585B (en) | Parapoxvirus for conditioning for and treatment of coronavirus infections | |
GB202103578D0 (en) | Prevention and treatment of infections including those caused by coronavirus | |
GB2595513B (en) | Treatment of infections | |
IL307872A (en) | Novel compositions and methods for treating coronavirus infections | |
EP4146240A4 (en) | Methods of treating or preventing coronavirus infection | |
EP4121038A4 (en) | Compositions and methods for the treatment of coronavirus infection and respiratory compromise | |
EP4121099A4 (en) | Methods of treating viral infections and health consequences | |
EP4132503A4 (en) | Methods for treatment of coronavirus infections | |
GB201908544D0 (en) | Treatment and prevention of disease mediated by wwp2 | |
IL276627A (en) | Compositions for diagnosis and treatment of coronavirus infections | |
GB202005126D0 (en) | Treatment and prevention of viral infections | |
GB202014412D0 (en) | Treatment of coronavirus | |
EP4135719A4 (en) | Treatment of coronavirus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |